The Chinese-German Journal of Clinical Oncology

, Volume 6, Issue 6, pp 579–581

Primary clinical study on treatment with velcade for multiple myeloma

  • Caixia Li
  • Depei Wu
  • Aining Sun
  • Miao Miao
  • Yuejun Liu
  • Ye Zhao
  • Xiaohui Hu
  • Daoping Sun
Article

DOI: 10.1007/s10330-007-0104-6

Cite this article as:
Li, C., Wu, D., Sun, A. et al. Chin.- Ger. J. Clin. Oncol. (2007) 6: 579. doi:10.1007/s10330-007-0104-6

Abstract

Objective

To explore the outcome and side-effects in patients with multiple myeloma treated with velcade and combined chemotherapy.

Methods

6 patients with multiple myeloma were treated with the combination of velcade and dexamethasone or DVD (V-DVD regimen) chemotherapy.

Results

6 patients responded to treatment. 4 patients achieved complete remission (CR), 1 achieved partial remission (PR) and 1 achieved micro responded (MR). Major toxicities consisted of peripheral neuropathy, thrombocytopenia and hepatic impairment.

Conclusion

Velcade combined chemotherapy is an effective and safety treatment for patients with multiple myeloma.

Key words

velcademultiple myelomatreatment

Copyright information

© Editorial Office of Chinese-German Journal of Clinical Oncology 2007

Authors and Affiliations

  • Caixia Li
    • 1
  • Depei Wu
    • 1
  • Aining Sun
    • 1
  • Miao Miao
    • 1
  • Yuejun Liu
    • 1
  • Ye Zhao
    • 1
  • Xiaohui Hu
    • 1
  • Daoping Sun
    • 1
  1. 1.Department of HematologyThe First Affilated Hospital of Soochow UniversitySuzhouChina